Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value, Liabilities Measured on Recurring Basis

Our financial instruments measured at fair value on a recurring basis were as follows at the dates indicated:

	Condensed Consolidated Balance Sheet Caption	Fair Value at March 31, 2020
(in thousands)		Level 1		Level 2		Level 3		Total
Liabilities:
Interest rate swap contract	Other long-term liabilities	$	—	$	699	$	—	$	699
Contingent consideration	Accrued expenses and other current liabilities	—		—		922		922
Total Liabilities		$	—	$	699	$	922	$	1,621

	Condensed Consolidated Balance Sheet Caption	Fair Value at December 31, 2019
(in thousands)		Level 1		Level 2		Level 3		Total
Liabilities:
Interest rate swap contract	Other long-term liabilities	$	—	$	206	$	—	$	206
Contingent consideration	Accrued expenses and other current liabilities	—		—		1,568		1,568
Total Liabilities		$	—	$	206	$	1,568	$	1,774

Schedule of Interest Rate Derivatives

Details of the outstanding swap contract as of March 31, 2020, which is a pay fixed and receive floating contract, are as follows:

Swap Maturity	Notional Value (in thousands)		Pay Fixed Rate		Receive Floating Rate	Floating Rate Reset Terms
October 1, 2025	$	8,255	2.07750	%	One-Month LIBOR	Monthly

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

A reconciliation of our liabilities that are measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2020 is as follows:

(in thousands)	Conscious Wholesale Contingent Consideration
Balance at December 31, 2019	$	1,568
Foreign currency translation adjustments	(31)
Gains from fair value adjustments included in results of operations	(615)
Balance at March 31, 2020	$	922